CNXU Conexeu Sciences Inc.
Company Analysis
Latest News
🟢 Conexeu Sciences is trading 6.94% up today; no confirmed catalyst identified
Conexeu Sciences is trading at $10.08 (+6.94%), with no confirmed catalyst identified. - No company announcement or filing dated August 20–21, 2026, was...
🟢 Conexeu Sciences is trading 5% up today with no clear catalyst identified
Conexeu Sciences is trading 5.14% up now at $9.42, though the specific catalyst remains unclear. - No company announcement or filing dated August 20, 2026 was...
🔴 Conexeu Sciences is trading 14.71% down today with no clear catalyst identified
Conexeu Sciences is trading at $8.52, down -14.71%, with no clear company-specific catalyst identified. - The decline reversed its August 18, 2026 close of...
🔴 Conexeu Sciences is trading 7.16% down today with no clear catalyst identified
Conexeu Sciences is trading 7.16% down at $9.28, with the move appearing catalyst-unclear. - It reversed the August 18, 2026 close of $9.99; no new...
🟢 Conexeu Sciences is trading 15.73% up today; no confirmed company-specific catalyst
Conexeu Sciences is trading 15.73% up at $10.30, with no confirmed company-specific catalyst identified for August 17, 2026. • Momentum follows gains of...
🟢 Conexeu Sciences is trading 10.34% up in pre-market with no confirmed catalyst
Conexeu Sciences is trading $9.82 (+10.34%) in pre-market, with the move appearing momentum-driven and no confirmed catalyst identified. - Shares rose 11.67%...
🟢 Conexeu Sciences is trading 6.74% up in pre-market amid momentum and broader risk-on sentiment
Conexeu Sciences is trading at $9.50, up 6.74% in pre-market, with the move appearing driven mainly by momentum and broader risk-on sentiment. - Available...
🟢 Conexeu Sciences is trading 11.67% up today
Conexeu Sciences is trading 11.67% up now at $8.90, extending its August 13, 2026 gain of 9.03%; no clearer company-specific catalyst was identified. - The...
🟢 Conexeu Sciences is trading 5% up today
Conexeu Sciences is trading 5.23% up at $8.39 on August 14, 2026, with no clear catalyst identified. - The company is scheduled to present tissue-regeneration...